Startup Venture
Unicircles Rank: 1
| Founded in 2007
Nivalis/ N30Pharma is developing a novel class of disease modifying therapies
Community Valuation
Undervalued
(1 vote undervalued, 0 votes overvalued)
Sector:
Biotech / Health Care
Growth Stage:
Not provided